FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2403487814> ?p ?o ?g. }

• W2403487814 abstract "Purpose/Objective(s): A recent meta-analysis of 22 randomized trials accrued between 1964-86 demonstrated significantly higher rates of locoregional failure (LRF), total failure (TF) and breast-cancer mortality in women with 1-3 positive (+) axillary lymph nodes (ALN) who did not receive radiotherapy after mastectomy (mast.). Given the improvements in diagnostic and therapeutic approaches, the challenge today is whether breast cancer patients with T1-T2 tumors with 1-3+ ALN have similar substantial risk that routinely warrants the delivery of post mastectomy radiotherapy (PMRT). We further set out to explore whether the risk of failure varies by breast cancer subtype. Materials/Methods: We reviewed patients with pathologic T1-2N1 breast cancer treated with initial mast. and adjuvant systemic therapy (ST) from 2000-2013. The primary endpoint was LRF, defined as a recurrence in either the ipsilateral chestwall or regional lympatics (axillary, internal mammary, or supraclavicular nodes). Secondary endpoints include rates of TF (LRF or distant metastases), disease-free survival (DFS, failure or death), and overall survival (OS). Patients were classified into 3 basic subtypes: hormone receptor positive/HER2 negative (HR+), HER2 positive (HER2+), and triple negative (TN). Survival analysis was performed using the Kaplan-Meier method. The log-rank test was used to compare survival between groups. Results : We identified 550 eligible patients from our prospectively maintained cancer registry. Median follow-up was 5 years. Baseline characteristics included median age 53 yrs, 61% pathologic T2, 39% grade 3, 48% with lymphovascular invasion. Subtypes included 72% HR+ (n=393), 16% HER2+ (n=89), 12% TN (n=66) and 0.4% unknown (n=2). Treatment included chemotherapy in 78% (n=428), PMRT in 15% (n=82), and anti-endocrine therapy in 70% (n=385). A median of 18 ALN (range, 1-68) were removed, 10% (N=55) had sentinel-lymph node biopsy only, and 17%(N=95) had micrometastases (N1mic) only. A total of 296 pts had 1+ node, 165 pts 2+ nodes and 89 pts 3+ nodes. The 5 yr LRF rate for the entire cohort was 3.9% and patients with 1+, 2+, and 3+ nodes had 5 yr LRF of 2.6%, 4.7% and 6.4%, respectively (p=0.79). The 5 yr LRF for HR+, HER2+ and TN was 3.9%, 1.5%, and 6.6%, respectively (p=0.39). When stratified by 1+, 2+ or 3+ nodes, the 5 yr LRF for HR+ vs. HER2+ vs. TN were 2.4%, 6.8%, and 0% vs. 5.8%, 15.4%, and 0% vs. 5.7%, 0%, and 4.8%, p=0.43. The 5 yr TF, DFS, and OS rates for HR+, HER2+ and TN were 90.5% vs. 88.5%. vs. 83.6% (p=0.76); 84.9% vs. 82.6% vs. 79.2% (p=0.85); and 91.4% vs. 86.2% vs. 81.3% (p=0.83). Conclusions : In a cohort of patients with T1-2N1 breast cancer treated with modern therapy, we found low rates of LRF which did not vary amongst HR+, HER2+ and TN patients. In particular, HR+ patients with 1+ LN had extremely low rates of LRF Given these low recurrence rates, caution should be given in routinely recommending PMRT for every woman with 1-3+ ALN after mast. and adjuvant ST. Citation Format: Bazan JG, Majithia L, Quick AM, Terando AM, Agnese D, Mrozek E, Farrar W, White JR. Locoregional failure rates do not vary by breast cancer subtype after mastectomy in a modern cohort of patients with T1-2 tumors with 1-3 pathologically involved lymph nodes. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-12-01." @default.
• W2403487814 created "2016-06-24" @default.
• W2403487814 creator A5021950466 @default.
• W2403487814 creator A5026671964 @default.
• W2403487814 creator A5029557021 @default.
• W2403487814 creator A5030098070 @default.
• W2403487814 creator A5033557142 @default.
• W2403487814 creator A5040907089 @default.
• W2403487814 creator A5064437942 @default.
• W2403487814 creator A5091191948 @default.
• W2403487814 date "2016-02-15" @default.
• W2403487814 modified "2023-09-27" @default.
• W2403487814 title "Abstract P3-12-01: Locoregional failure rates do not vary by breast cancer subtype after mastectomy in a modern cohort of patients with T1-2 tumors with 1-3 pathologically involved lymph nodes" @default.
• W2403487814 doi "https://doi.org/10.1158/1538-7445.sabcs15-p3-12-01" @default.
• W2403487814 hasPublicationYear "2016" @default.
• W2403487814 type Work @default.
• W2403487814 sameAs 2403487814 @default.
• W2403487814 citedByCount "0" @default.
• W2403487814 crossrefType "proceedings-article" @default.
• W2403487814 hasAuthorship W2403487814A5021950466 @default.
• W2403487814 hasAuthorship W2403487814A5026671964 @default.
• W2403487814 hasAuthorship W2403487814A5029557021 @default.
• W2403487814 hasAuthorship W2403487814A5030098070 @default.
• W2403487814 hasAuthorship W2403487814A5033557142 @default.
• W2403487814 hasAuthorship W2403487814A5040907089 @default.
• W2403487814 hasAuthorship W2403487814A5064437942 @default.
• W2403487814 hasAuthorship W2403487814A5091191948 @default.
• W2403487814 hasConcept C121608353 @default.
• W2403487814 hasConcept C126322002 @default.
• W2403487814 hasConcept C143998085 @default.
• W2403487814 hasConcept C203092338 @default.
• W2403487814 hasConcept C2777649267 @default.
• W2403487814 hasConcept C2777757722 @default.
• W2403487814 hasConcept C2778740770 @default.
• W2403487814 hasConcept C2779013556 @default.
• W2403487814 hasConcept C509974204 @default.
• W2403487814 hasConcept C530470458 @default.
• W2403487814 hasConcept C535046627 @default.
• W2403487814 hasConcept C71924100 @default.
• W2403487814 hasConcept C72563966 @default.
• W2403487814 hasConceptScore W2403487814C121608353 @default.
• W2403487814 hasConceptScore W2403487814C126322002 @default.
• W2403487814 hasConceptScore W2403487814C143998085 @default.
• W2403487814 hasConceptScore W2403487814C203092338 @default.
• W2403487814 hasConceptScore W2403487814C2777649267 @default.
• W2403487814 hasConceptScore W2403487814C2777757722 @default.
• W2403487814 hasConceptScore W2403487814C2778740770 @default.
• W2403487814 hasConceptScore W2403487814C2779013556 @default.
• W2403487814 hasConceptScore W2403487814C509974204 @default.
• W2403487814 hasConceptScore W2403487814C530470458 @default.
• W2403487814 hasConceptScore W2403487814C535046627 @default.
• W2403487814 hasConceptScore W2403487814C71924100 @default.
• W2403487814 hasConceptScore W2403487814C72563966 @default.
• W2403487814 hasLocation W24034878141 @default.
• W2403487814 hasOpenAccess W2403487814 @default.
• W2403487814 hasPrimaryLocation W24034878141 @default.
• W2403487814 hasRelatedWork W1817692493 @default.
• W2403487814 hasRelatedWork W2017349267 @default.
• W2403487814 hasRelatedWork W2046826982 @default.
• W2403487814 hasRelatedWork W2056641603 @default.
• W2403487814 hasRelatedWork W2072601853 @default.
• W2403487814 hasRelatedWork W2075153856 @default.
• W2403487814 hasRelatedWork W2083210296 @default.
• W2403487814 hasRelatedWork W2092273257 @default.
• W2403487814 hasRelatedWork W2110566533 @default.
• W2403487814 hasRelatedWork W2142714808 @default.
• W2403487814 hasRelatedWork W2228564575 @default.
• W2403487814 hasRelatedWork W2358352129 @default.
• W2403487814 hasRelatedWork W2792817409 @default.
• W2403487814 hasRelatedWork W2944154762 @default.
• W2403487814 hasRelatedWork W2974925204 @default.
• W2403487814 hasRelatedWork W3030120394 @default.
• W2403487814 hasRelatedWork W3099388026 @default.
• W2403487814 hasRelatedWork W3208913464 @default.
• W2403487814 hasRelatedWork W3209279634 @default.
• W2403487814 hasRelatedWork W2739498030 @default.
• W2403487814 isParatext "false" @default.
• W2403487814 isRetracted "false" @default.
• W2403487814 magId "2403487814" @default.
• W2403487814 workType "article" @default.